These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19302179)

  • 21. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis.
    Ucak S; Ekmekci TR; Basat O; Koslu A; Altuntas Y
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):517-22. PubMed ID: 16684277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
    Valenti L; Pulixi E; Fracanzani AL; Dongiovanni P; Maggioni M; Orsatti A; Gianni C; Fargion S
    J Hepatol; 2005 Dec; 43(6):944-50. PubMed ID: 16143422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome.
    Maruyama S; Hirayama C; Horie Y; Yorozu K; Maeda K; Inoue M; Fujii Y; Umeki K; Koda M
    Hepatogastroenterology; 2007 Mar; 54(74):493-8. PubMed ID: 17523306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of host insulin resistance on fibrosis and response to interferon in chronic hepatitis C.
    Moţa M; Popa S; Mota E; Diaconescu I; Gheorghiţoiu I; Panduru M
    Rom J Intern Med; 2008; 46(2):105-12. PubMed ID: 19284081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
    Chen H; Ren A; Hu S; Mo W; Xin X; Jia W
    Diabetes Res Clin Pract; 2007 Mar; 75(3):327-32. PubMed ID: 16930761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients.
    Elsammak M; Refai W; Elsawaf A; Abdel-Fattah I; Abd Elatti E; Ghazal A
    Curr Med Res Opin; 2005 Apr; 21(4):527-34. PubMed ID: 15899101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
    Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
    Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon therapy on glucose metabolism in children with chronic hepatitis B.
    Kuloğlu Z; Berberoğlu M; Kansu A; Demirçeken F; Doğanci T; Ocal G; Girgin N
    Turk J Pediatr; 2010; 52(6):594-601. PubMed ID: 21428191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.
    Miyaaki H; Ichikawa T; Nakao K; Takeshita S; Shibata H; Ozawa E; Akiyama M; Miuma S; Eguchi K
    Intervirology; 2008; 51(6):394-9. PubMed ID: 19258717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of preoperative carbohydrate loading on the changes in serum tumor necrosis factor receptors 1 and 2 and insulin resistance in patients of colon carcinoma].
    An GQ; Zhao XL; Gao YC; Wang GY; Yu YM
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2041-4. PubMed ID: 19080431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.
    Harrison SA
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2009 Jun; 81(6):1032-9. PubMed ID: 19382270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interferon modulates serum concentrations of 7S domain of type IV collagen according to the pretreatment levels in patients with chronic hepatitis C].
    Maeda K; Yonezawa M; Yamada S; Suou T
    Rinsho Byori; 2006 Nov; 54(11):1101-5. PubMed ID: 17240830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study.
    Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G
    HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose metabolism, insulin resistance, and renal pathology in non-diabetic chronic kidney disease.
    Ikee R; Hamasaki Y; Oka M; Maesato K; Mano T; Moriya H; Ohtake T; Kobayashi S
    Nephron Clin Pract; 2008; 108(2):c163-8. PubMed ID: 18259103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response.
    Rao HY; Wei L; Li J; Zhang LF; Chen HY; Zhu LM; Liu F; Sun Y; Wang H
    Hepatogastroenterology; 2009; 56(90):328-34. PubMed ID: 19579592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.